268 related articles for article (PubMed ID: 35371068)
21. Genetic Influences in Cancer-Associated Myositis.
Patasova K; Lundberg IE; Holmqvist M
Arthritis Rheumatol; 2023 Feb; 75(2):153-163. PubMed ID: 36053262
[TBL] [Abstract][Full Text] [Related]
22. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
24. Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept.
Anuja AK; Mehta P; Singh MK; Singh H; Nath A; Hashim Z; Khan A; Gupta M; Misra DP; Agarwal V; Gupta L
Reumatol Clin (Engl Ed); 2023 Mar; 19(3):143-149. PubMed ID: 36906390
[TBL] [Abstract][Full Text] [Related]
25. Pathology Features of Immune and Inflammatory Myopathies, Including a Polymyositis Pattern, Relate Strongly to Serum Autoantibodies.
Pestronk A; Choksi R
J Neuropathol Exp Neurol; 2021 Sep; 80(9):812-820. PubMed ID: 34363679
[TBL] [Abstract][Full Text] [Related]
26. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
27. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
[TBL] [Abstract][Full Text] [Related]
28. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
Haq SA; Tournadre A
Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expansion of circulating CD4
Zhang L; Li W; Cai Y; Liu X; Peng Q; Liang L
Int J Rheum Dis; 2020 Mar; 23(3):397-405. PubMed ID: 31883219
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
de Padilla CM; Reed AM
Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
Ernste FC; Reed AM
Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
[TBL] [Abstract][Full Text] [Related]
34. Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients.
Young-Glazer J; Cisneros A; Wilfong EM; Smith SA; Crofford LJ; Bonami RH
Arthritis Res Ther; 2021 Jan; 23(1):33. PubMed ID: 33468230
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
36. Evolving classification and role of muscle biopsy in diagnosis of inflammatory myopathies.
Swain M; Uppin M
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S241-S251. PubMed ID: 35562156
[TBL] [Abstract][Full Text] [Related]
37. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg Ø; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA;
Ann Rheum Dis; 2016 Aug; 75(8):1558-66. PubMed ID: 26362759
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.
Ghannam K; Martinez-Gamboa L; Spengler L; Krause S; Smiljanovic B; Bonin M; Bhattarai S; Grützkau A; Burmester GR; Häupl T; Feist E
PLoS One; 2014; 9(8):e104048. PubMed ID: 25098831
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.
Tiniakou E; Mammen AL
Clin Rev Allergy Immunol; 2017 Feb; 52(1):20-33. PubMed ID: 26429706
[TBL] [Abstract][Full Text] [Related]
40. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
